HCV RNA monitoring during therapy is used to tailor treatment duration in HCV genotype 1 infection, and molecular assays are used to assess the end-of-treatment and, most importantly the sustained virological response, i.e
Compounded oral GIP/GLP-1 dual-agonist, 5mg to 25mg daily across seven dose levels
Retatrutide is currently being investigated in clinical trials and has not yet been approved
Chronic pancreatitis (CP) is a known risk factor of pancreatic cancer, with incidence increasing over time from diagnosis
Risk factors for these health problems include long-term use of anorectics, taking higher than the recommended dosage, and combining more than one anorectic agent
The Standard American Diet high in refined starches and ultra-processed foods is known to promote inflammation and worsen rheumatoid arthritis symptoms